An overview of phase II studies of docetaxel in patients with metastatic breast cancer

This publication has 8 references indexed in Scilit:

• Coping with toxicities of docetaxel (TaxotereTM)
  Annals of Oncology, 1993
• 3′-Deamino-3′-(2-methoxy-4-morpholinyl)-doxorubicin (FCE 23762): A new anthracycline derivative with enhanced cytotoxicity and reduced cardiotoxicity
  European Journal Of Cancer, 1993
• The influence of chemotherapy on survival after recurrence in breast cancer—a population-based study of patients treated in the 1950s, 1960s and 1970s
  European Journal Of Cancer, 1993
• Breast Cancer
  New England Journal of Medicine, 1992
• Effects of Taxotere and taxol on in vitro colony formation of freshly explanted human tumor cells
  Anti-Cancer Drugs, 1992
• Systemic Therapy of Advanced Breast Cancer
  Drugs, 1992
• Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer
  JNCI Journal of the National Cancer Institute, 1991
• Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of Taxol
  JNCI Journal of the National Cancer Institute, 1991